biglycan
| GO Term | Evidence Code | PMID |
|---|---|---|
| bone development | ||
| articular cartilage development |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region | ||
| extracellular region | ||
| extracellular space | ||
| Golgi lumen | ||
| cell surface |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular matrix structural constituent | ||
| protein binding | ||
| glycosaminoglycan binding | ||
| cytokine binding | ||
| extracellular matrix structural constituent conferring compression resistance |
| InterPro |
|---|
| Leucine-rich repeat domain superfamily |
| Leucine-rich repeat, typical subtype |
| Leucine-rich repeat |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0111861 | Meester-Loeys syndrome | |
| DOID:0112150 | X-linked spondyloepimetaphyseal dysplasia |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025